January 2014 FDA Recall Drug by Watson Laboratories Inc
D-1053-2014 - Failed Tablet/Capsule Specifications; Product contains broken tablets.

This Class II drug recall was voluntarily initiated by Watson Laboratories Inc on January 15, 2014 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specifications; product contains broken tablets.. The product was distributed in Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI. and the recall is currently terminated.

Recall Number: D-1053-2014

Reason for Recall
Failed Tablet/Capsule Specifications; Product contains broken tablets.
Initiated
01-15-2014
Reported
02-05-2014
Quantity
717 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Watson Laboratories Inc
Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI.
Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by Watson Laboratories, Inc., Corona, CA 92880. Distributed by: Watson Pharma, Inc. NDC: 00591-0517-01.

Batch or Lot Expiration Information

Lot# : 697316A, Expiry: Mar 2015.